[go: up one dir, main page]

GB0411047D0 - Dosage form - Google Patents

Dosage form

Info

Publication number
GB0411047D0
GB0411047D0 GB0411047A GB0411047A GB0411047D0 GB 0411047 D0 GB0411047 D0 GB 0411047D0 GB 0411047 A GB0411047 A GB 0411047A GB 0411047 A GB0411047 A GB 0411047A GB 0411047 D0 GB0411047 D0 GB 0411047D0
Authority
GB
United Kingdom
Prior art keywords
dosage form
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0411047A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Hull
Original Assignee
University of Hull
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Hull filed Critical University of Hull
Priority to GB0411047A priority Critical patent/GB0411047D0/en
Publication of GB0411047D0 publication Critical patent/GB0411047D0/en
Priority to AU2004251496A priority patent/AU2004251496B2/en
Priority to BRPI0411623-2A priority patent/BRPI0411623A/en
Priority to EP04743123.4A priority patent/EP1638538B1/en
Priority to MYPI20042537A priority patent/MY149933A/en
Priority to CA2530645A priority patent/CA2530645C/en
Priority to PCT/GB2004/002775 priority patent/WO2005000280A2/en
Priority to KR1020057025138A priority patent/KR101190766B1/en
Priority to CN2004800243309A priority patent/CN1842325B/en
Priority to MXPA05013965A priority patent/MXPA05013965A/en
Priority to JP2006516482A priority patent/JP5059402B2/en
Ceased legal-status Critical Current

Links

GB0411047A 2003-06-27 2004-05-18 Dosage form Ceased GB0411047D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GB0411047A GB0411047D0 (en) 2004-05-18 2004-05-18 Dosage form
JP2006516482A JP5059402B2 (en) 2003-06-27 2004-06-28 Formulation comprising sporopolenin-containing outer membrane skin and method of using the formulation in the manufacture of a therapeutic drug
MYPI20042537A MY149933A (en) 2003-06-27 2004-06-28 Dosage form comprising an exine coating of sporopollenin or derivatized sporopollenin
BRPI0411623-2A BRPI0411623A (en) 2003-06-27 2004-06-28 pharmaceutical or dietary dosage form, sporopolenin, method for forming a primary amine-functionalized sporopolenin or other exine coating, method for forming a polyamino-functionalized sporopolenin or other spore exine coating, method for obtaining an amino acid functionalized sporopolenin or other spore exine coating, functionalized sporopolenin or other spore exine coating, dietary or flavoring dosage form, method of filling spore exine coatings, use of the dosage and method of oral application of an active ingredient
EP04743123.4A EP1638538B1 (en) 2003-06-27 2004-06-28 Dosage form
AU2004251496A AU2004251496B2 (en) 2003-06-27 2004-06-28 Dosage form comprising an exine coating of sporopollenin or derivatized sporopollenin
CA2530645A CA2530645C (en) 2003-06-27 2004-06-28 Dosage form
PCT/GB2004/002775 WO2005000280A2 (en) 2003-06-27 2004-06-28 Dosage form comprising an exine coating of sporopollenin or derivatized sporopollenin
KR1020057025138A KR101190766B1 (en) 2003-06-27 2004-06-28 Dosage form comprising an exine coating of sporopollenin or derivatized sporopollenin
CN2004800243309A CN1842325B (en) 2003-06-27 2004-06-28 Formulation
MXPA05013965A MXPA05013965A (en) 2003-06-27 2004-06-28 Dosage form comprising an exine coating of sporopollenin or derivatized sporopollenin.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0411047A GB0411047D0 (en) 2004-05-18 2004-05-18 Dosage form

Publications (1)

Publication Number Publication Date
GB0411047D0 true GB0411047D0 (en) 2004-06-23

Family

ID=32607507

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0411047A Ceased GB0411047D0 (en) 2003-06-27 2004-05-18 Dosage form

Country Status (1)

Country Link
GB (1) GB0411047D0 (en)

Similar Documents

Publication Publication Date Title
IL251539A0 (en) Unitary pharmaceutical dosage form
IL182614A0 (en) Pharmaceutical compounds
GB0419849D0 (en) Pharmaceutical combination
IL181229A0 (en) Noncardiotoxic pharmaceutical compounds
GB0427455D0 (en) Dosage forms
GB0423964D0 (en) Dosage form
GB0513984D0 (en) Dosage form
GB0512453D0 (en) Dosage unit
IL180316A0 (en) Quinolone-containing medicinal composition
IL180487A0 (en) Medicament
EP1753400A4 (en) Ziprasidone dosage form
GB0424742D0 (en) Pharmaceutical compounds
ZA200605666B (en) Solid dosage form
GB0428554D0 (en) Pharmaceutical compounds
GB0411047D0 (en) Dosage form
GB0424994D0 (en) Dosage form
GB0409098D0 (en) Medicament
GB0426942D0 (en) Medicament
GB0417777D0 (en) Pharmaceutical combination
GB0315019D0 (en) Dosage form
GB0522989D0 (en) Dosage form
HU2883U (en) Medicinal chair-cushion
GB0403149D0 (en) Medicament
GB0408878D0 (en) Medicinal compounds
GB0418567D0 (en) Pharmaceutical combination

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)